BMO Capital upgraded Tetraphase Pharmaceuticals (NASDAQ: TTPH) from Market Perform to Outperform with a price target of $10.00.Analyst M. Ian ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE